Kraig Biocraft Laboratories, Inc. (KBLB)

KBLB Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cost of Revenue	0.03	0.03	3,683	13,092	14,793
Gross Profit	-0.03	-0.03	-3,683	-13,092	-14,793
Selling, General & Admin	2.35	1.94	2.56	4.45	2.4
Research & Development	0.24	0.18	0.2	0.09	0.22
Other Operating Expenses	797,406	779,742	734,427	516,332	627,197
Operating Expenses	2.59	2.12	2.76	4.53	2.62
Operating Income	-2.61	-2.12	-2.76	-4.53	-2.62
Interest Income	109,559	0	0.01	0	0.01
Interest Expense	-484,658	0.61	0.66	0.39	0.29
Other Expense / Income	594,217	1.11	4.63	0.05	-
Pretax Income	-3.03	-3.84	-8.05	-4.97	-2.91
Income Tax	0	1.72	0.66	0.39	0.29
Net Income	-3.03	-5.56	-8.71	-5.36	-3.2
Shares Outstanding (Basic)	1,033	974	878	849	836
Shares Outstanding (Diluted)	1,033	974	878	849	836
Shares Change	6.04%	11.02%	3.41%	1.56%	2.29%
EPS (Basic)	-0.00	-0.01	-0.01	-0.01	-0.00
EPS (Diluted)	-0.00	-0.01	-0.01	-0.01	-0.00
Free Cash Flow	-1.25	-1.89	-1.9	-1.25	-1.19
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
EBITDA	-2.59	-3.2	-7.44	-4.56	-2.58
Depreciation & Amortization	0.03	0.03	0.03	0.03	0.03
EBIT	-2.61	-3.23	-7.46	-4.58	-2.62

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.